Background: Immune checkpoint inhibitors (ICIs) represent a paradigm shift in the development of cancer treatment. However, it remains to be clarified whether the benefits that they confer diff
Activity refers to the presence of inflammation in any region of the colon and is not restricted to the site of the tissue biopsy, while inflammation refers specifically to the site of the tissue biop
